This is to inform you that Sudarshan Industries Inc. has been incorporated as a wholly-owned subsidiary in United States of America. Details provioded in the Letter and its Annexure.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sudarshan Pharma Industries has incorporated a wholly-owned subsidiary called Sudarshan Industries Inc. (Sudarshan USA) in Delaware, USA, on June 5, 2026. The company subscribed to 1,00,00,000 shares of US $0.00001 each, totaling roughly US $100 (~₹9,600), giving it 100% ownership. The subsidiary will handle buying, selling, manufacturing, importing, and exporting pharmaceuticals, APIs, drugs, chemicals, and healthcare products to grow the company's customer base in the US market. Joint Managing Director Sachin Mehta has been appointed as the first director, and the investment was made under the RBI's automatic route under FEMA.
This is a small, initial step towards entering the US pharma market, with negligible immediate financial impact given the token capital outlay. Future capital infusion into this subsidiary will be the real indicator of how serious the US push is, so investors should watch for follow-up disclosures on actual business operations or further funding.